KIORA PHARMACEUTICALS INC EYEG
COM NEW · Common Stock · CUSIP 49721T309
2
institutional holders
-23 vs Q1 2024
455.6k
shares reported held*
$1.9mreported value*
1 new
0 added
1 reduced
24 sold out
net sold ≈ $44.9m (-10.7m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $4.20.
Trends to Q2 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 10 |
| Q4 2022 | 12 |
| Q1 2023 | 15 |
| Q2 2023 | 19 |
| Q3 2023 | 15 |
| Q4 2023 | 16 |
| Q1 2024 | 25 |
| Q2 2024 | 2 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 6 | 3 |
| Q1 2023 | 7 | 6 |
| Q2 2023 | 9 | 5 |
| Q3 2023 | 5 | 7 |
| Q4 2023 | 6 | 4 |
| Q1 2024 | 14 | 5 |
| Q2 2024 | 1 | 25 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
CallsPuts
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2023 | $0 | $0 | — |
| Q4 2023 | $0 | $0 | — |
| Q1 2024 | $4.3m | $0 | 0.00 |
| Q2 2024 | $0 | $0 | — |
Biggest buyers
| Stonepine Capital Management, LLC | New | +200.0k |
Biggest sellers
| AIGH Capital Management LLC | Sold out | -2.3m |
| Alyeska Investment Group, L.P. | Sold out | -2.2m |
| Rosalind Advisors, Inc. | Reduced | -2.0m |
| Nantahala Capital Management, LLC | Sold out | -1.9m |
| Velan Capital Investment Management LP | Sold out | -1.1m |
| ADAR1 Capital Management, LLC | Sold out | -1.1m |
| CAPTRUST FINANCIAL ADVISORS | Sold out | -80.0k |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -37.2k |
| XTX Topco Ltd | Sold out | -24.9k |
| VANGUARD GROUP INC | Sold out | -24.6k |
Holders, Q2 2024
| Manager | Shares | Change |
|---|---|---|
| Rosalind Advisors, Inc. 0.85% of their portfolio | 255.6k $1.1m | Reduced -2.0m |
| Stonepine Capital Management, LLC 0.77% of their portfolio | 200.0k $840.0k | New |